Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02508038
Title Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Wisconsin, Madison
Indications

neuroblastoma

sarcoma

hematologic cancer

Therapies

Zoledronic acid

Fludarabine + Melphalan

Melphalan

Tacrolimus

anti-thymocyte globulin

Mycophenolate mofetil

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.